NCT05380505 is a NA clinical trial of Racially Congruent Ads in Food Choices, sponsored by NYU Langone Health.

Who is sponsoring NCT05380505?

NCT05380505 is sponsored by NYU Langone Health.

What drugs are being tested in NCT05380505?

Interventions in NCT05380505: Racially Congruent Ads, Racially Incongruent Ads.

What condition does NCT05380505 study?

NCT05380505 studies Food Choices.

Is NCT05380505 still recruiting?

NCT05380505 is currently completed. Last updated 16 May 2025.

Are results published for NCT05380505?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-05-16 · How we verify

NCT05380505

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Social Media Ads on Food Choice

Completed NA Results posted Last updated 16 May 2025

What this trial tests

NA trial testing Racially Congruent Ads in Food Choices in 1,252 participants. Completed in 4 March 2023.

Timeline

16 March 2022

Primary endpoint
4 March 2023

4 March 2023

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	double
Primary purpose	prevention
Enrollment	1,252
Start date	16 March 2022
Primary completion	4 March 2023
Estimated completion	4 March 2023
Sites	1 location across United States

Drugs / interventions tested

Racially Congruent Ads
Racially Incongruent Ads

Conditions studied

Food Choices — all drugs for Food Choices →

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 13 to 17, any sex, with Food Choices. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Calories Purchased Primary · 15 minutes

Group	Value	95% CI
Condition 1: Race Congruent Ads	458	117 – 750
Condition 2: Race Incongruent Ads	477	117 – 750

Attitude Toward Ad Secondary · 15 minutes

Attitude will be reported on a Likert scale of 1 to 100 (1 = likeable, 100 = unlikeable). The higher the score, the less likeable the ad is to the participant.

Group	Value	95% CI
Condition 1: Race Congruent Ads	73.4	0 – 100
Condition 2: Race Incongruent Ads	68.7	0 – 100

Time Spent Viewing Ad Secondary · 15 minutes

Time spend viewing ad.

Group	Value	95% CI
Condition 1: Race Congruent Ads	10.3	0.2 – 755.2
Condition 2: Race Incongruent Ads	9.3	0.1 – 236.9

Sponsor's own description

This is a randomized trial to examine the influence of race-congruent food marketing on social media among Black and White adolescents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Food Choices

Currently open trials in the same condition.

NCT07531849 — Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas · NA · recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05380505 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 16 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05380505.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing